
HealthEquity (HQY) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Apr 2025Income Metrics
Revenue
330.8M
Gross Profit
224.3M
67.80%
Operating Income
84.4M
25.50%
Net Income
53.9M
16.30%
EPS (Diluted)
$0.61
Balance Sheet Metrics
Total Assets
3.4B
Total Liabilities
1.3B
Shareholders Equity
2.1B
Debt to Equity
0.61
Cash Flow Metrics
Operating Cash Flow
64.7M
Free Cash Flow
48.6M
Revenue & Profitability Trend
HealthEquity Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.2B | 999.6M | 861.7M | 756.6M | 733.6M |
Cost of Goods Sold | 422.5M | 377.0M | 369.8M | 331.8M | 318.2M |
Gross Profit | 777.3M | 622.6M | 491.9M | 424.8M | 415.3M |
Gross Margin % | 64.8% | 62.3% | 57.1% | 56.1% | 56.6% |
Operating Expenses | |||||
Research & Development | 239.5M | 218.8M | 193.4M | 157.4M | 124.8M |
Selling, General & Administrative | 223.0M | 182.9M | 166.3M | 144.0M | 134.5M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 462.5M | 401.7M | 359.7M | 301.4M | 259.3M |
Operating Income | 202.9M | 128.1M | 37.7M | 40.6M | 80.0M |
Operating Margin % | 16.9% | 12.8% | 4.4% | 5.4% | 10.9% |
Non-Operating Items | |||||
Interest Income | 13.9M | 12.1M | 1.8M | 1.5M | 1.0M |
Interest Expense | 60.6M | 55.5M | 48.4M | 36.6M | 34.9M |
Other Non-Operating Income | -40.1M | -9.8M | -29.1M | -72.2M | -42.0M |
Pre-tax Income | 116.0M | 75.0M | -38.1M | -66.7M | 4.1M |
Income Tax | 19.3M | 19.3M | -12.0M | -22.5M | -4.7M |
Effective Tax Rate % | 16.7% | 25.8% | 0.0% | 0.0% | -113.4% |
Net Income | 96.7M | 55.7M | -26.1M | -44.3M | 8.8M |
Net Margin % | 8.1% | 5.6% | -3.0% | -5.9% | 1.2% |
Key Metrics | |||||
EBITDA | 379.7M | 294.0M | 200.2M | 181.0M | 202.0M |
EPS (Basic) | $1.11 | $0.65 | $-0.31 | $-0.53 | $0.12 |
EPS (Diluted) | $1.09 | $0.64 | $-0.31 | $-0.53 | $0.12 |
Basic Shares Outstanding | 86870000 | 85564000 | 84442000 | 83133000 | 74235000 |
Diluted Shares Outstanding | 86870000 | 85564000 | 84442000 | 83133000 | 74235000 |
Income Statement Trend
HealthEquity Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 295.9M | 404.0M | 254.3M | 225.4M | 328.8M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 118.0M | 104.9M | 96.8M | 87.4M | 72.8M |
Inventory | - | - | - | - | - |
Other Current Assets | 63.8M | 48.6M | 31.8M | 38.5M | 58.6M |
Total Current Assets | 477.7M | 557.4M | 382.9M | 351.3M | 460.2M |
Non-Current Assets | |||||
Property, Plant & Equipment | 43.2M | 48.4M | 56.5M | 63.6M | 89.5M |
Goodwill | 4.5B | 4.1B | 4.2B | 4.3B | 3.4B |
Intangible Assets | 1.2B | 835.9M | 936.4M | 973.1M | 767.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 71.6M | 67.9M | 52.2M | 49.8M | 37.4M |
Total Non-Current Assets | 3.0B | 2.6B | 2.7B | 2.8B | 2.3B |
Total Assets | 3.4B | 3.2B | 3.1B | 3.1B | 2.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 14.4M | 12.0M | 13.9M | 27.5M | 1.6M |
Short-term Debt | 10.0M | 9.4M | 27.7M | 20.9M | 76.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 156.3M | 117.1M | 131.1M | 153.2M | 204.7M |
Non-Current Liabilities | |||||
Long-term Debt | 1.1B | 923.7M | 966.8M | 987.3M | 998.4M |
Deferred Tax Liabilities | 55.8M | 68.7M | 82.7M | 99.8M | 119.7M |
Other Non-Current Liabilities | 23.0M | 19.3M | 12.7M | 14.2M | 8.8M |
Total Non-Current Liabilities | 1.2B | 1.0B | 1.1B | 1.1B | 1.1B |
Total Liabilities | 1.3B | 1.1B | 1.2B | 1.3B | 1.3B |
Equity | |||||
Common Stock | 9.0K | 9.0K | 8.0K | 8.0K | 8.0K |
Retained Earnings | 209.3M | 205.6M | 149.9M | 176.1M | 220.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.1B | 2.0B | 1.9B | 1.9B | 1.4B |
Key Metrics | |||||
Total Debt | 1.1B | 933.1M | 994.5M | 1.0B | 1.1B |
Working Capital | 321.4M | 440.3M | 251.8M | 198.2M | 255.5M |
Balance Sheet Composition
HealthEquity Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 96.7M | 55.7M | -26.1M | -44.3M | 8.8M |
Depreciation & Amortization | 162.5M | 153.1M | 161.2M | 137.2M | 115.9M |
Stock-Based Compensation | 96.4M | 77.2M | 62.6M | 52.8M | 42.9M |
Working Capital Changes | -6.5M | -33.1M | -33.4M | 1.6M | -18.1M |
Operating Cash Flow | 338.3M | 241.7M | 150.6M | 127.4M | 151.2M |
Investing Activities | |||||
Capital Expenditures | -2.1M | -1.7M | -3.4M | -8.9M | -13.1M |
Acquisitions | - | 0 | 0 | -504.5M | 0 |
Investment Purchases | - | - | - | 0 | 0 |
Investment Sales | - | 0 | 0 | 2.4M | 0 |
Investing Cash Flow | -2.1M | -1.7M | -3.4M | -511.1M | -13.1M |
Financing Activities | |||||
Share Repurchases | -121.5M | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 736.9M | 0 | 0 | 950.0M | 0 |
Debt Repayment | -561.9M | -54.4M | -8.8M | -1.0B | -239.1M |
Financing Cash Flow | 48.1M | -53.5M | -9.4M | 385.1M | 43.9M |
Free Cash Flow | -165.6M | 196.8M | 31.5M | 3.9M | 84.7M |
Net Change in Cash | 384.3M | 186.5M | 137.9M | 1.4M | 182.0M |
Cash Flow Trend
HealthEquity Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
65.16
Forward P/E
24.19
Price to Book
3.64
Price to Sales
6.21
PEG Ratio
24.19
Profitability Ratios
Profit Margin
9.80%
Operating Margin
25.50%
Return on Equity
5.77%
Return on Assets
4.57%
Financial Health
Current Ratio
4.06
Debt to Equity
52.11
Beta
0.54
Per Share Data
EPS (TTM)
$1.37
Book Value per Share
$24.49
Revenue per Share
$14.30
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
hqy | 7.7B | 65.16 | 3.64 | 5.77% | 9.80% | 52.11 |
Veeva Systems | 45.6B | 59.15 | 7.33 | 14.06% | 27.34% | 1.24 |
Ge Healthcare | 34.0B | 15.25 | 3.50 | 25.80% | 11.22% | 107.67 |
Waystar Holding | 6.2B | 64.55 | 1.95 | 2.81% | 8.50% | 39.60 |
BrightSpring Health | 3.9B | 87.04 | 2.54 | 2.67% | 0.52% | 155.46 |
Privia Health | 2.6B | 192.00 | 3.79 | 2.71% | 0.78% | 0.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.